Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Environ Res ; 251(Pt 2): 118698, 2024 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-38518906

RESUMO

Sixty-eight morphologically distinct isolates of marine actinomycetes were derived from seashore, mangrove, and saltpan ecosystems located between the Palk Strait and Gulf of Mannar region, Bay of Bengal, Tamilnadu. Twenty-five (36.8%) isolates exhibited anti-mycotic activity against Candida albicans and Cryptococcus neoformans in preliminary screening, and 4 isolates with prominent activity were identified and designated at the genus level as Streptomyces sp. VPTS3-I, Streptomyces sp. VPTS3-2, Streptomyces sp. VPTSA1-4 and Streptomyces sp. VPTSA1-8. All the potential antagonistic isolates were further characterized with phenotypic and genotypic properties including 16S rRNA gene sequencing and identified species level as Streptomyces afghaniensis VPTS3-1, S. matensis VPTS3-2, S. tuirus VPTSA1-4 and S. griseus VPTSA1-8. In addition, the active fractions from the potential antagonistic streptomycetes were extracted with organic solvents by shake flask culture method and the anti-mycotic efficacies were evaluated. The optimization parameters for the production of the anti-mycotic compound were found to be pH between 7 and 8, the temperature at 30ᵒC, the salinity of 2%, incubation of 9 days, and starch and KNO3 as the suitable carbon and nitrogen sources respectively in starch casein medium.


Assuntos
Antifúngicos , Streptomyces , Índia , Streptomyces/genética , Streptomyces/metabolismo , Antifúngicos/farmacologia , Microbiologia do Solo , Candida albicans/efeitos dos fármacos , Cryptococcus neoformans/efeitos dos fármacos , Baías/microbiologia , RNA Ribossômico 16S/genética
2.
Microb Pathog ; 121: 166-172, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-29775727

RESUMO

Around 120 actinobacterial colonies were isolated from various regions of marine East coast region of Tamil Nadu, India. Among them, 33 were morphologically distinct and they were preliminarily screened for their antibacterial activity against Pseudomonas fluorescens, Vibrio cholerae, V. parahaemolyticus, V. alginolyticus, and Aeromonas hydrophila by cross-streak plate technique. Among the isolated, the isolate ECR64 exhibited maximum zone of inhibition against fish pathogenic bacteria. The crude bioactive compounds were extracted from the isolate ECR64 using different organic solvents which exhibited maximum antibacterial activity. Separation and purification of the bioactive compounds were made by column chromatography which yielded 27 fractions and were re-chromatographed to obtain the active compound. Ultra violet (UV), Fourier transform infrared (FT-IR) and nuclear magnetic resonance (NMR) spectral studies were used to predict the structure of the active compound which was identified as methyl-4,8-dimethylundecanate. The potential isolate ECR64 was identified as Streptomyces albogriseolus by phylogenetic, phenotypic and genotypic (16S rRNA gene sequence) analyses. The identified compound methyl-4,8-dimethylundecanate can be used as potential and alternative drug in disease management of aquaculture.


Assuntos
Antibacterianos/farmacologia , Streptomyces/química , Aeromonas hydrophila/efeitos dos fármacos , Aeromonas hydrophila/metabolismo , Animais , Antibacterianos/química , Antibacterianos/isolamento & purificação , Aquicultura , Doenças dos Peixes/tratamento farmacológico , Doenças dos Peixes/microbiologia , Peixes/microbiologia , Índia , Espectroscopia de Ressonância Magnética , Filogenia , Pseudomonas fluorescens/efeitos dos fármacos , RNA Ribossômico 16S/genética , Espectroscopia de Infravermelho com Transformada de Fourier , Vibrio alginolyticus/efeitos dos fármacos , Vibrio cholerae/efeitos dos fármacos , Vibrio parahaemolyticus/efeitos dos fármacos
3.
J Basic Clin Physiol Pharmacol ; 17(2): 71-86, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16910313

RESUMO

PURPOSE: To study the effect of piperine, an alkaloid, on thyroid hormones and apolipoproteins in high-fat-diet (HFD) and antithyroid drug-induced hyperlipidemic rats. EXPERIMENTAL: Male Wistar rats were first divided into two groups, control diet and high-fat diet (HFD) and then subdivided into four subgroups of ten animals each. The animals were treated with the following regimens for 10 weeks: 1% carboxymethyl cellulose; 10 mg carbimazole (CM)/kg body weight; 10 mg CM + 40 mg piperine/kg body weight, and 10 mg CM + 2 mg atorvastatin /ATV//kg body weight. Lipid profiles, hormone levels, and apolipoprotein levels were studied in all groups. RESULTS: HFD and/or CM administration significantly elevated the plasma levels of total cholesterol, VLDL, LDL, triglycerides, free fatty acids, and phospholipids, but significantly reduced the HDL levels. Moreover, CM administration significantly reduced apo A-I levels and T3, T4 and testosterone levels while significantly elevating plasma apo B, thyroid stimulating hormone (TSH) and insulin levels. The simultaneous administration of piperine and HFD significantly reduced plasma lipids and lipoproteins levels, except for HDL, which was significantly elevated. Piperine supplementation also improved the plasma levels of apo A-I, T3, T4, testosterone, and I and significantly reduced apo B, TSH, and insulin to near normal levels. CONCLUSIONS: The data presented here provide evidence that piperine possesses thyrogenic activity, thus modulating apolipoprotein levels and insulin resistance in HFD-fed rats, opening a new view in the management of dyslipidemia by dietary supplementation with nutrients.


Assuntos
Alcaloides/farmacologia , Apolipoproteínas/metabolismo , Benzodioxóis/farmacologia , Hormônios/sangue , Hiperlipidemias/tratamento farmacológico , Hipolipemiantes/farmacologia , Piper/química , Piperidinas/farmacologia , Alcamidas Poli-Insaturadas/farmacologia , Animais , Gorduras na Dieta/farmacologia , Hiperlipidemias/sangue , Insulina/sangue , Lipídeos/sangue , Masculino , Ratos , Ratos Wistar , Testosterona/sangue , Hormônios Tireóideos/sangue
4.
Basic Clin Pharmacol Toxicol ; 103(6): 538-45, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19067681

RESUMO

In the present study, the antihyperlipidaemic efficacy of ethanol extract of Gymnema montanum leaves was investigated in alloxan-induced diabetic rats and the effect was compared to standard hypoglycaemic drug, glibenclamide. Male adult albino Wistar rats were injected with freshly prepared solution of alloxan monohydrate (150 mg/kg body weight) to induce diabetes. After 2 weeks, the rats with moderate diabetes were administered G. montanum leaves (200 mg/kg body weight) for 21 days by gastric lavage, after which serum, liver and kidney samples were analysed for lipid profile, lipoprotein changes and fatty acid composition. While the alloxan-induced diabetic rats showed a significant increase in the levels of cholesterol, triglycerides and free fatty acids, the levels in the animals treated with G. montanum leaves were considerably reduced and restored to near normal values. Antihyperlipidaemic effects of G. montanum leaves were found to be comparable with that of glibenclamide. Similarly, G. montanum leaves treatment resulted in reversal of alterations observed in the plasma lipoproteins (high-density lipoprotein, low-density lipoprotein and very high-density lipoprotein-cholesterol) and fatty acid composition in serum, liver and kidney of alloxan-induced rats. Our study suggests that phytochemicals present in G. montanum may play an important role in suppressing the elevated lipid profile in diabetes and may be useful for the prevention and/or early treatment of diabetes-associated hyperlipidaemia.


Assuntos
Diabetes Mellitus Experimental/tratamento farmacológico , Ácidos Graxos/metabolismo , Gymnema , Hiperlipidemias/tratamento farmacológico , Hipolipemiantes/uso terapêutico , Lipídeos/sangue , Preparações de Plantas/uso terapêutico , Animais , Glicemia/análise , Diabetes Mellitus Experimental/sangue , Diabetes Mellitus Experimental/enzimologia , Hiperlipidemias/sangue , Hiperlipidemias/enzimologia , Insulina/sangue , Rim/enzimologia , Fígado/enzimologia , Masculino , Fitoterapia , Extratos Vegetais/uso terapêutico , Folhas de Planta , Ratos , Ratos Wistar
5.
Cell Biochem Funct ; 24(6): 491-8, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16927417

RESUMO

The main aim of this study was to investigate the effect of piperine on erythrocyte antioxidant status in high fat diet (HFD) and antithyroid drug induced hyperlipidemic rats. Male Wistar rats were divided into eight groups. The first four groups were fed a control diet and in addition were given respectively 1% carboxymethyl cellulose (CMC); 10 mg/kg body weight carbimazole (CM); 10 mg CM + 40 mg/kg body weight piperine and 10 mg CM + 2 mg/kg body weight atorvastatin (ATV). A similar pattern was followed for the next four groups except that they were all fed HFD instead of the control diet. Erythrocyte osmotic fragility, total cholesterol, phospholipids, lipid peroxidation products, enzymic and non-enzymic antioxidant status were studied in all experimental groups. Significantly increased osmotic fragility, total cholesterol/phospholipid ratio, thiobarbituric acid reactive substances and lipid hydroperoxides were observed in the plasma and erythrocytes of HFD fed and CM treated rats compared to the control. Superoxide dismutase, catalase, glutathione peroxidase, vitamin E and reduced glutathione in erythrocytes and vitamin C in the plasma were also significantly lowered in HFD fed, antithyroid drug treated rats compared to control animals. Concurrent piperine supplementation along with HFD and antithyroid drug administration normalized erythrocyte osmotic fragility, reduced lipid peroxidation, and improved the enzymic and non-enzymic antioxidant status compared to those rats that did not receive piperine. Thus, our results indicate that piperine supplementation markedly protects erythrocytes from oxidative stress by improving the antioxidant status in HFD fed antithyroid drug treated rats.


Assuntos
Alcaloides/uso terapêutico , Antioxidantes/metabolismo , Benzodioxóis/uso terapêutico , Gorduras na Dieta/administração & dosagem , Eritrócitos/metabolismo , Hiperlipidemias/tratamento farmacológico , Piper nigrum/química , Piperidinas/uso terapêutico , Alcamidas Poli-Insaturadas/uso terapêutico , Alcaloides/farmacologia , Animais , Antitireóideos , Benzodioxóis/farmacologia , Dieta , Modelos Animais de Doenças , Eritrócitos/efeitos dos fármacos , Eritrócitos/enzimologia , Hiperlipidemias/induzido quimicamente , Hipolipemiantes/farmacologia , Hipolipemiantes/uso terapêutico , Masculino , Estrutura Molecular , Fragilidade Osmótica/efeitos dos fármacos , Piperidinas/farmacologia , Alcamidas Poli-Insaturadas/farmacologia , Ratos , Ratos Wistar , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismo
6.
Pharmacol Res ; 46(3): 251-5, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12220968

RESUMO

Hyperlipidemia is an associated complication of diabetes mellitus. Many spices and herbs are known to be hypoglycaemic. Cuminum cyminum belonging to the family Apiaceae is widely used in Ayurvedic medicine for the treatment of dyspepsia, diarrhoea and jaundice. The present work was done to study the role of C. cyminum supplementation on the plasma and tissue lipids in alloxan diabetic rats. Oral administration of 0.25 g kg(-1) body weight of C. cyminum for 6 weeks to diabetic rats resulted in significant reduction in blood glucose and an increase in total haemoglobin and glycosylated haemoglobin. It also prevented a decrease in body weight. C. cyminum treatment also resulted in a significant reduction in plasma and tissue cholesterol, phospholipids, free fatty acids and triglycerides. Histological observations demonstrated significant fatty changes and inflammatory cell infiltrates in diabetic rat pancreas. But supplementation with C. cyminum to diabetic rats significantly reduced the fatty changes and inflammatory cell infiltrates. Moreover, C. cyminum supplementation was found to be more effective than glibenclamide in the treatment of diabetes mellitus.


Assuntos
Cuminum , Diabetes Mellitus Experimental/tratamento farmacológico , Hipolipemiantes/uso terapêutico , Fitoterapia , Extratos Vegetais/uso terapêutico , Aloxano/administração & dosagem , Animais , Glicemia/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Carboidratos/urina , Colesterol/sangue , Diabetes Mellitus Experimental/induzido quimicamente , Ácidos Graxos/sangue , Feminino , Hemoglobinas/efeitos dos fármacos , Hemoglobinas/metabolismo , Fosfolipídeos/sangue , Ratos , Ratos Wistar , Triglicerídeos/sangue
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa